Resources Library
Webinar: RBQM 101: Getting Started with Risk-Based Quality Management
In this free webinar, the featured speakers will discuss the importance of making risk-based quality management (RBQM) accessible. It will […]
October 18, 2021
ARG Collaborating with Cytokinetics on the COURAGE-ALS Trial of Reldesemtiv
Our partner Cytokinetics, Incorporated announced August 2, 2021 that COURAGE-ALS, a Phase 3 clinical trial of Reldesemtiv in patients with ALS, is open to enrollment.
August 11, 2021
Do You Have Visibility into Your CRO’s processes?
We are cost-conscious, financially responsible, and considerate of budgets, yet understand and clearly communicate how additional activities could add value and reduce time to market.
July 6, 2021
Xtalks Webinar: ALS Biomarkers in Drug Development
Atlantic Research Group will be presenting a webinar via Xtalks on Tuesday, June 22, 2021 at 11am EST. Please register […]
May 28, 2021
Does Your CRO Value Every Single Patient?
Every patient counts. While large-scale intricately-designed studies can afford to lose patients, clinical trials for rare patient populations are not buffered for atrophy. ARG emphasizes that every patient is vital; in fact, we place the utmost importance on every data point in every study.
May 20, 2021
BPL And Atlantic Research Group Enter Into Long-term Collaboration
28 April, 2021–Bio Products Laboratory (BPL), a leading manufacturer of plasma-derived protein therapies headquartered in Elstree, UK, today announced the […]
April 28, 2021